Monica Elizabeth Jarrett, FNP-C | |
1040 Greenwood Springs Blvd, Greenwood, IN 46143-7975 | |
(317) 893-0888 | |
(317) 893-0815 |
Full Name | Monica Elizabeth Jarrett |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 7 Years |
Location | 1040 Greenwood Springs Blvd, Greenwood, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508369778 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WE0003X | Registered Nurse - Emergency | 28171959A (Indiana) | Secondary |
363LF0000X | Nurse Practitioner - Family | 71007910 (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
Franciscan Health Mooresville | Mooresville, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Franciscan Physician Network | 3072790682 | 989 |
News Archive
Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the degree to which proteins that can cause diseases (target proteins) bind to chemical substances that could become candidate drugs.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The Myelin Repair Foundation (MRF) today announced the results of a new peer-reviewed research study published in Nature Neuroscience that demonstrates functional improvement in immune response modulation and myelin repair with factors derived from mesenchymal stem cell (MSC) treatment in animal models of multiple sclerosis.
A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.
› Verified 5 days ago
Entity Name | Franciscan Physician Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the degree to which proteins that can cause diseases (target proteins) bind to chemical substances that could become candidate drugs.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The Myelin Repair Foundation (MRF) today announced the results of a new peer-reviewed research study published in Nature Neuroscience that demonstrates functional improvement in immune response modulation and myelin repair with factors derived from mesenchymal stem cell (MSC) treatment in animal models of multiple sclerosis.
A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Monica Elizabeth Jarrett, FNP-C Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Monica Elizabeth Jarrett, FNP-C 1040 Greenwood Springs Blvd, Greenwood, IN 46143-7975 Ph: (317) 893-0888 |
News Archive
Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the degree to which proteins that can cause diseases (target proteins) bind to chemical substances that could become candidate drugs.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The Myelin Repair Foundation (MRF) today announced the results of a new peer-reviewed research study published in Nature Neuroscience that demonstrates functional improvement in immune response modulation and myelin repair with factors derived from mesenchymal stem cell (MSC) treatment in animal models of multiple sclerosis.
A team of US-based scientists recently developed a novel vaccine candidate against SARS-CoV-2, the causative pathogen of COVID-19. The vaccine is composed of extracellular vesicles of Salmonella typhimurium incorporated with the spike receptor-binding domain (RBD) of SARS-CoV-2. Upon intranasal administration in hamsters, the vaccine induces strong blood antibody titers and protects against severe COVID-19.
› Verified 5 days ago
Marilyn Ann Jones, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2867 Bloomsbury S, Greenwood, IN 46143 Phone: 317-402-6341 | |
Patricia Justine Irvin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 700 Us Highway 31 S, Greenwood, IN 46143 Phone: 317-883-0567 | |
Laura Walradth, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1703 W Stones Crossing Rd Ste 200, Greenwood, IN 46143 Phone: 317-781-7188 Fax: 317-781-7140 | |
Meagan Lee Mcdurfee, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2355 Endress Pl Suite A, Greenwood, IN 46143 Phone: 317-530-1811 Fax: 317-963-1621 | |
Haleigh Ann Tharp, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 333 E County Line Rd Ste B, Greenwood, IN 46143 Phone: 317-497-6333 Fax: 317-497-6334 | |
Hannah E Mason, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Mrs. Cassie A Himes, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1703 W Stones Crossing Rd Ste 310, Greenwood, IN 46143 Phone: 317-887-6060 Fax: 317-859-5944 |